Profile

    Corporate information


    Registration country
    Investment activity status
    Active investor

    Company type

    A world leader in in-silico structure-based drug design, de novo drug design.

    Funding rounds


    Profile Country Notes
    Avlar Bioventures Ltd Venture investor in biotechnology and healthcare United Kingdom


    Profile Country Notes
    ET Capital Ltd Venture capital firm United Kingdom


    Profile Country Notes
    Excalibur Fund Managers Ltd United Kingdom

    Current and past shareholders

    Investor Contacts Round
    Avlar Bioventures Ltd
    Venture investor in biotechnology and healthcare
    +44 (1954) 211-515
    N/A
    ET Capital Ltd
    Venture capital firm
    +44 (1223) 236-632
    N/A
    Excalibur Fund Managers Ltd logo Excalibur Fund Managers Ltd
    +44 (20) 7887-7642
    N/A